Indications
Nausea or vomiting. Also given ahead of time to prevent vomiting in stimulant overdose and with high-dose glucagon.
Contraindications
Hypersensitivity. Use with apomorphine (profound hypotension and loss of consciousness reported). Suspected or known prolonged QT; avoid in congenital long QT syndrome.
Adult dose
Nausea/vomiting: 4 mg IV/PO/SL, or 4 or 8 mg SL of the ODT
Stimulant overdose, to prevent vomiting: 4-8 mg slow IV over 2-5 min, or 4-8 mg IM, or 8 mg ODT
Acute mountain sickness with vomiting: 4 mg IV, PO or SL every 6 hours
Pediatric dose
Nausea/vomiting (6 months to 14 years): 0.15 mg/kg IV/PO (max 4 mg), or 2 mg SL for ages 1-5, 4 mg ODT for age 6 and older
Stimulant overdose, to prevent vomiting: 0.15 mg/kg slow IV over 2-5 min
Route
IV, IM, PO, SL (ODT)
Special considerations
It can prolong the QT and cause torsades, so EKG monitoring is recommended if your patient has electrolyte problems, CHF, a slow rhythm, or other QT-prolonging drugs on board. It has no effect on dopamine receptors, so it does not cause extrapyramidal symptoms. It's the preferred antiemetic in children, but it can sedate very young children. In the first trimester of pregnancy, the guideline recommends metoclopramide with diphenhydramine over ondansetron.
Follow your local protocols. Sources: National Model EMS Clinical Guidelines (NASEMSO, 2022): Nausea-Vomiting; Stimulant Poisoning/Overdose; Altitude Illness; Calcium Channel Blocker Poisoning/Overdose. Levels from the National EMS Scope of Practice Model (2019).